Standout Papers

Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer 2006 2026 2012 2019 2.4k
  1. Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer (2006)
    Charles E. Geyer, Deborah Lindquist et al. New England Journal of Medicine

Immediate Impact

6 by Nobel laureates 18 from Science/Nature 93 standout
Sub-graph 1 of 20

Citing Papers

Acute myeloid leukaemia
2023 Standout
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia
2022 Standout

Works of Stephen D. Rubin being referenced

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial
2018

Author Peers

Author Last Decade Papers Cites
Stephen D. Rubin 2583 1312 1101 17 3.9k
Neville Davidson 3634 1151 1230 25 4.9k
Ashley E. Winkler 3862 2444 1138 12 7.2k
Judy Dering 2155 1294 1461 40 3.5k
Jan B. Vermorken 3032 2106 1292 43 5.4k
Cristina Oliva 4700 1995 1404 66 6.1k
Agnieszka Jagiełło-Gruszfeld 3356 2308 1832 56 5.2k
Anna Berkenblit 1356 1262 1611 57 3.1k
Gwen Fyfe 5606 2343 3007 13 8.9k
Dimosthenis Skarlos 4753 2094 1457 103 6.2k
Jonathan Polikoff 2437 1982 683 70 4.6k

All Works

Loading papers...

Rankless by CCL
2026